TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor May 10, 1996